{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:51:23Z","timestamp":1764791483853,"version":"3.46.0"},"reference-count":5,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"DOI":"10.5858\/arpa.2022-0097-le","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:42:55Z","timestamp":1664466175000},"page":"1181-1182","source":"Crossref","is-referenced-by-count":3,"title":["Enterochromaffin-like Cell Hyperplasia as Identification Marker of Autoimmune Gastritis in Patients With\n                    <i>Helicobacter pylori<\/i>\n                    Infection in the Context of Gastric Premalignant Lesions"],"prefix":"10.5858","volume":"146","author":[{"given":"Xiaopei","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon C. W.","family":"Spaander","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenny M.","family":"Fuhler","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"2022092919423848300_i1543-2165-146-10-1181-b01","doi-asserted-by":"crossref","unstructured":"Choudhuri\n              J,\n            \n            \n              Hall\n              S,\n            \n            \n              Castrodad-Rodriguez\n              CA,\n            \n            et al.\n          \n          Features that aid identification of autoimmune gastritis in a background of active Helicobacter pylori infection.\n\t\t\t\t\tArch Pathol Lab Med.\n\t\t\t\t\t2021;145(12):1536\u20131543.","DOI":"10.5858\/arpa.2020-0615-OA"},{"key":"2022092919423848300_i1543-2165-146-10-1181-b02","doi-asserted-by":"crossref","unstructured":"Pimentel-Nunes\n              P,\n            \n            \n              Lib\u00e2nio\n              D,\n            \n            \n              Marcos-Pinto\n              R,\n            \n            et al.\n          \n          Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.\n\t\t\t\t\tEndoscopy.\n\t\t\t\t\t2019;51(4):365\u2013388.","DOI":"10.1055\/a-0859-1883"},{"key":"2022092919423848300_i1543-2165-146-10-1181-b03","unstructured":"Veijola\n              LI,\n            \n            \n              Oksanen\n              AM,\n            \n            \n              Sipponen\n              PI,\n            \n            \n              Rautelin\n              HIK.\n            \n          \n          Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.\n\t\t\t\t\tWorld J Gastroenterol.\n\t\t\t\t\t2010;16(1):83\u201388."},{"key":"2022092919423848300_i1543-2165-146-10-1181-b04","doi-asserted-by":"crossref","unstructured":"den Hollander\n              WJ,\n            \n            \n              Holster\n              IL,\n            \n            \n              den Hoed\n              CM,\n            \n            et al.\n          \n          Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.\n\t\t\t\t\tGut.\n\t\t\t\t\t2019;68(4):585\u2013593.","DOI":"10.1136\/gutjnl-2017-314498"},{"key":"2022092919423848300_i1543-2165-146-10-1181-b05","doi-asserted-by":"crossref","unstructured":"Nishizawa\n              T,\n            \n            \n              Watanabe\n              H,\n            \n            \n              Yoshida\n              S,\n            \n            et al.\n          \n          Decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis.\n\t\t\t\t\tScand J Gastroenterol.\n\t\t\t\t\t2022;57(2):143\u2013148.","DOI":"10.1080\/00365521.2021.1994642"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/146\/10\/1181\/3126223\/i1543-2165-146-10-1181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/146\/10\/1181\/3126223\/i1543-2165-146-10-1181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:18Z","timestamp":1764790758000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/146\/10\/article-p1181.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":5,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,9,29]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0097-le","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}